1 Dirt Cheap Warren Buffett Stock to Buy Now

Berkshire Hathaway‘s (NYSE: BRK.A) (NYSE: BRK.B) CEO, Warren Buffett, undoubtedly has a keen eye for value. Berkshire’s book value per share, which is often used as a proxy for the diversified holding company’s intrinsic value, increased at a blistering compound annual growth rate of 18.7% over the period from 1965 to 2021.

And as a direct result of Buffett’s laser-like focus on owning large chunks of companies with deep value, Berkshire’s stock delivered a whopping 3,641,613% total return on capital for shareholders from 1964 to 2021. Buffett, in short, is the undisputed of king of bargain hunting.

Which Berkshire holdings are the most compelling bargains right now? I think the e-commerce titan Amazon (NASDAQ: AMZN) is easily Buffett’s most undervalued stock holding right now. Here’s why.  

Image source: Getty Images.

Pandemic headwinds have hurt the tech giant’s core business

E-commerce behemoth Amazon lost roughly a third of its value over the prior 12 months. Amazon’s stock has been under heavy pressure of late due to the company’s decision to bulk up in order to meet the surge in demand during the early days of the pandemic.

As consumers have steadily migrated back to shopping at brick-and-mortar stores, however, Amazon has been forced to resize its bloated e-retailer operation. The net result of this miscue is that Amazon posted its first net loss in seven years in the first quarter of 2022.  

The sluggish performance of Amazon’s core business segment, though, has arguably been overplayed by bears. After all, the company is still seeing healthy levels of revenue growth in other key segments like its advertising unit, cloud-computing division, and subscription-based services. Keeping with this theme, Amazon is expected to return to high double-digit revenue growth as soon as next year.  

Amazon’s healthcare unit is grossly underappreciated 

The real reason to hoard Amazon’s stock at these levels, though, has yet to even make a debut on most analysts’ reports. The long and short of it is Amazon’s steady move into the massive $800 billion U.S. healthcare sector has the potential to be a major catalyst for the company’s share price within a few short years. 

In 2018, Amazon kicked its plan to disrupt the embattled U.S. healthcare space into high gear through its acquisition of the online pharmacy PillPack. Since then, the company has developed a telemedicine program known as Amazon Care. Its fledgling telemedicine venture has recently received additional support through a partnership with Teladoc Health aimed at providing access to healthcare via Alexa-enabled devices. Amazon’s nearly $4 billion acquisition of 1Life Healthcare, also known as One Medical, earlier this month will also extend its virtual and in-person primary healthcare capabilities once the deal closes later this year.

The bottom line is that Amazon’s best-in-class logistics platform, integrated digital ecosystem, unprecedented access to consumer data, and vast financial resources put it in an ideal position to revolutionize healthcare in the United States. Now, the market clearly hasn’t put much stock into this possibility — evinced by Amazon’s shares trading at a meager two times 2023 projected sales right now. Savvy investors, though, will definitely want to consider the enormous growth prospects of Amazon’s steady march into healthcare. 

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. George Budwell has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Amazon, Berkshire Hathaway (B shares), and Teladoc Health. The Motley Fool recommends the following options: long January 2023 $200 calls on Berkshire Hathaway (B shares), short January 2023 $200 puts on Berkshire Hathaway (B shares), and short January 2023 $265 calls on Berkshire Hathaway (B shares). The Motley Fool has a disclosure policy.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

  • This field is for validation purposes and should be left unchanged.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Rebate Rewards

Level 2 Rebate

Deposit $2,000 and get $200 Rebate
$ 200 Rebate
  • 3 Simple Steps
  • 1. Register Using The Link Below (Promo-Code: WEBREBATE)
  • 2. Deposit $2,000 and place one trade at any non-Austalian market within 30 calendar days
  • 3. Receive Your $200 Rebate

Level 1 Rebate

Deposit $1,000 and get $100 Rebate
$ 100 Rebate
  • 3 Simple Steps
  • 1. Register Using The Link Below (Promo-Code: WEBREBATE)
  • 2. Deposit $1,000 and place one trade at any non-Austalian market within 30 calendar days
  • 3. Receive Your $100 Rebate

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex Securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Act Fast - Promotion Ends In
Click Here To Get Started
Act Fast - Promotion Ends In
Click Here For More Info